AI assistant
XERO LIMITED — Director's Dealing 2016
Feb 4, 2016
66106_rns_2016-02-04_3e72abd1-4b7e-42be-bbd3-857d8eccec4f.pdf
Director's Dealing
Open in viewerOpens in your device viewer
DocuSign Envelope ID: FDF874B0-3FB1-4B4E-BD98-E0CD2DB3FA30

Ongoing Disclosure Notice
Full name(s): Name of listed issuer:
Director or senior manager giving disclosure
Name of related body corporate (if applicable):
Position held in listed issuer:
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| ITo NZX Limited: and | . |
|---|---|
Name of listed issuer: |
. |
| Date this disclosure made: | |
| Date of last disclosure: | |
| Xero Limited (XRO) | |
|---|---|
| February 2016 | |
| 7 April 2015 |
| Andy Lark | |
|---|---|
| Xero Limited (XRO) | |
| Not applicable | |
| Chief Marketing Officer |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
| Class of affected quoted financial products: | Options to acquire ordinary shares in Xero Limited (Options) |
|
|---|---|---|
| Nature of the affected relevant interest(s): | Holder of Options to subscribe for Ordinary Shares in Xero (Ordinary Shares) (each Option entitling the holder to subscribe for one Ordinary Share) subject to the terms of the Xero Limited Restricted Stock Unit Plan (AU) AU Plan) |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | None | |
| Number held in class after acquisition or disposal: | 125,000 | |
| Current registered holder(s): | Not applicable | |
| Registered holder(s) once transfers are registered: | Andy Lark |
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
| Type of affected derivative: | Not applicable |
|---|---|
| Class of underlying financial products: | Not applicable |
| Details of affected derivative- | |
| The notional value of the derivative (if any) or the notional amount of underlying financial prode (if any): |
Not applicable |
| A statement as to whether the derivative is cash settled or physically settled: | Not applicable |
| Maturity date of the derivative (if any): | Not applicable |
| Expiry date of the derivative (if any): | Not applicable |
| The price specified in the terms of the derivative (if any): | Not applicable |
| Any other details needed to understand how the amount of the consideration payable under t derivative or the value of the derivative is affected by the value of the underlying financial products: |
Not applicable |
| For that derivative,- | |
| Parties to the derivative: | Not applicable |
| If the director or senior manager is not a party to the derivative, the nature of the relevant inter- in the derivative: |
Not applicable |
| Details of transactions giving rise to acquisition or disposal | |
| Total number of transactions to which notice relates: | |
| Details of transactions requiring disclosure- | |
| $D = 1 - 1$ is $I = 0$ $I = 1 - 1$ | $1.7 - 1.7 - 1.00$ |
| 1 February 2016 |
|---|
| Grant of Options under the Al Plan |
| Not applicable |
Date of transaction:
Nature of transaction:
Name of any other party or parties to the transaction (if known):
DocuSign Envelope ID: FDF874B0-3FB1-4B4E-BD98-E0CD2DB3FA30
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: |
The Options have been granted pursuant to the AU Plan as part of the remuneration of Andy Lark (in his role as Chief Marketing Officer of Xero Limited). The exercise price is NZ\$17.14 per Option (being the 20 day volume weighted average market price of Ordinary Shares of Xero Limited on the NZX Main Board through to 29 January 2016). The Options will vest (meaning that they are able to be exercised, subject to any final expiration date) in equal percentages on 31 March 2017, 2018 and 2019, subject to the terms of the AU Plan, including Andy Lark's continued employment with the Xero Limited Group on each vesting date |
|---|---|
| Number of financial products to which the transaction related: | $\mathbf{1}$ |
| If the lissuer has a financial products trading policy that prohibits directors or senior managers | |
| from trading during any period without written clearance (a closed period) include the following details- |
|
| Whether relevant interests were acquired or disposed of during a closed period: | Not applicable |
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: |
Not applicable |
| Date of the prior written clearance (if any): | Not applicable |
| Class of quoted financial products: | Unlisted conditional contractual right to be issued Ordinary Shares (Restricted Stock Units or RSUs) |
| Nature of relevant interest: | (a) Legal ownership of Ordinary Shares; (b) Holder of RSUs, subject to the terms of the AU Plan |
| For that relevant interest.- | |
| Number held in class: | (a) 15 750; (b) 70,000 |
| Current registered holder(s): | (a) Andy Lark; (b) Andy Lark |
| For a derivative relevant interest,- Type of derivative: |
Not applicable |
| Details of derivative,- | |
| The notional value of the derivative (if any) or the notional amount of underlying financial produ (if any): |
Not applicable |
| A statement as to whether the derivative is cash settled or physically settled: | Not applicable |
| Maturity date of the derivative (if any): | Not applicable |
| Expiry date of the derivative (if any): | Not applicable |
| The price's specified terms (if any): | Not applicable |
| Any other details needed to understand how the amount of the consideration payable under t derivative or the value of the derivative is affected by the value of the underlying financial products: |
Not applicable |
| For that derivative relevant interest,- | |
| Parties to the derivative: | Not applicable |
| If the director or senior manager is not a party to the derivative, the nature of the relevant inter in the derivative: |
Not applicable |
| Certification I certify that, to the best of my knowledge and belief, the information contained in this disclosu correct and that I am duly authorised to make this disclosure by all persons for whom it is made |
-DocuSigned by: Andy Lark $CB433BDBE6D24E0$ $2/4/2016$ | $16:07:27$ PT
Signature of director or officer:
Date of signature: